Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors-Reference-Cited by-同舟云学术

Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors

Published:2024-09 Issue:18 Volume:187 Page:4905-4925.e24
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Luo Yikai,Xia Yu,Liu Dan,Li Xiong,Li Huayi,Liu Jiahao,Zhou Dongchen,Dong Yu,Li Xin,Qian Yiyu,Xu Cheng,Tao Kangjia,Li Guannan,Pan Wen,Zhong Qing,Liu Xingzhe,Xu Sen,Wang Zhi,Liu Ronghua,Zhang Wei,Shan Wanying,Fang Tian,Wang Siyuan,Peng Zikun,Jin Ping,Jin Ning,Shi Shennan,Chen Yuxin,Wang Mengjie,Jiao Xiaofei,Luo Mengshi,Gong Wenjian,Wang Ya,Yao Yue,Zhao Yi,Huang Xinlin,Ji Xuwo,He Zhaoren,Zhao Guangnian,Liu Rong,Wu Mingfu,Chen Gang,Hong Li,Ma Ding,Fang Yong,Liang Han,Gao Qinglei

Publisher

Elsevier BV

Reference144 articles.

1. Prevalence of homologous recombination–related gene mutations across multiple cancer types;Heeke;JCO Precis. Oncol.,2018

2. Pan-cancer landscape of homologous recombination deficiency;Nguyen;Nat. Commun.,2020

3. Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD);Rempel;NPJ Precis. Oncol.,2022

4. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy;Farmer;Nature,2005

5. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase;Bryant;Nature,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD19+CD73+ B cells infiltration indicates poor prognosis and unfavorable responses to immunotherapy in gastric cancer;International Immunopharmacology;2024-11

2. Harnessing immune cells to leverage PARP inhibitors;Cell;2024-09

3. Single-sample gene set enrichment analysis reveals the clinical implications of immune-related genes in ovarian cancer;Frontiers in Molecular Biosciences;2024-08-05